{"id":"https://openalex.org/W2004133377","doi":"https://doi.org/10.1002/sim.2106","title":"Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control","display_name":"Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2004133377","doi":"https://doi.org/10.1002/sim.2106","mag":"2004133377","pmid":"https://pubmed.ncbi.nlm.nih.gov/15909291"},"language":"en","primary_location":{"id":"doi:10.1002/sim.2106","doi":"https://doi.org/10.1002/sim.2106","is_oa":false,"landing_page_url":"https://doi.org/10.1002/sim.2106","pdf_url":null,"source":{"id":"https://openalex.org/S55189604","display_name":"Statistics in Medicine","issn_l":"0277-6715","issn":["0277-6715","1097-0258"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Statistics in Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030308961","display_name":"Mourad Tighiouart","orcid":"https://orcid.org/0000-0001-8021-5690","observed_orcids":["https://orcid.org/0000-0001-8021-5690"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mourad Tighiouart","raw_affiliation_strings":["Department of Biostatistics and Winship Cancer Institute, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, USA. mourad_tighiouart@emory.org","Department of Biostatistics and Winship Cancer Institute, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Winship Cancer Institute, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, USA. mourad_tighiouart@emory.org","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]},{"raw_affiliation_string":"Department of Biostatistics and Winship Cancer Institute, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, U.S.A","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090472587","display_name":"Andr\u00e9 Rogatko","orcid":"https://orcid.org/0000-0001-8935-8890","observed_orcids":["https://orcid.org/0000-0001-8935-8890"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Rogatko","raw_affiliation_strings":["Department of Biostatistics and Winship Cancer Institute, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Winship Cancer Institute, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, U.S.A","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052171046","display_name":"James S. Babb","orcid":"https://orcid.org/0000-0003-1798-1186","observed_orcids":["https://orcid.org/0000-0003-1798-1186"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James S. Babb","raw_affiliation_strings":["Department of Radiology, NYU Medical Center, 560 First Avenue, New York, NY 10016, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, NYU Medical Center, 560 First Avenue, New York, NY 10016, U.S.A","institution_ids":["https://openalex.org/I4210086933"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5030308961"],"corresponding_institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":4.4871,"has_fulltext":false,"cited_by_count":101,"citation_normalized_percentile":{"value":0.94667221,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"24","issue":"14","first_page":"2183","last_page":"2196"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10243","display_name":"Statistical Methods and Bayesian Inference","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.906000018119812},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8289999961853027},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9810000061988831},{"id":"https://openalex.org/keywords/prior-distributions","display_name":"prior distributions","score":0.6639999747276306},{"id":"https://openalex.org/keywords/bayesian-analysis","display_name":"Bayesian analysis","score":0.40799999237060547},{"id":"https://openalex.org/keywords/trial-safety","display_name":"trial safety","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C107673813","wikidata":"https://www.wikidata.org/wiki/Q812534","display_name":"Bayesian probability","level":2,"score":0.6411009430885315},{"id":"https://openalex.org/C2776056953","wikidata":"https://www.wikidata.org/wiki/Q1182511","display_name":"De-escalation","level":2,"score":0.5877963900566101},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.461182177066803},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4334542155265808},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.42926186323165894},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.41588425636291504},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3765420913696289},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.36424052715301514},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35680004954338074},{"id":"https://openalex.org/C149782125","wikidata":"https://www.wikidata.org/wiki/Q160039","display_name":"Econometrics","level":1,"score":0.3462360203266144},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3019963204860687},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.2206236720085144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2132747769355774},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.10617315769195557},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001499","descriptor_name":"Bayes Theorem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/sim.2106","doi":"https://doi.org/10.1002/sim.2106","is_oa":false,"landing_page_url":"https://doi.org/10.1002/sim.2106","pdf_url":null,"source":{"id":"https://openalex.org/S55189604","display_name":"Statistics in Medicine","issn_l":"0277-6715","issn":["0277-6715","1097-0258"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Statistics in Medicine","raw_type":"journal-article"},{"id":"pmid:15909291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15909291","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Statistics in medicine","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8100000023841858,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2049313446","display_name":"SPRL--A MOLECULAR MARKER FOR BRONCHIAL PRENEOPLASIA","funder_award_id":"5k08ca069271-04","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G423874844","display_name":null,"funder_award_id":"CA92769","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4404861734","display_name":null,"funder_award_id":"CA069271","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8585820503","display_name":"Etiology of Toxic Response to Cancer Treatment","funder_award_id":"5r03ca092769-02","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W78553138","https://openalex.org/W92330624","https://openalex.org/W1972194651","https://openalex.org/W1973396713","https://openalex.org/W2045985885","https://openalex.org/W2053015923","https://openalex.org/W2056760934","https://openalex.org/W2076108528","https://openalex.org/W2103514815","https://openalex.org/W2134261496","https://openalex.org/W2138309709"],"related_works":["https://openalex.org/W2952060368","https://openalex.org/W2137656264","https://openalex.org/W2103514815","https://openalex.org/W2753632799","https://openalex.org/W2080277472","https://openalex.org/W2340140042","https://openalex.org/W2121289570","https://openalex.org/W2000052578","https://openalex.org/W1789298896","https://openalex.org/W3162245153"],"abstract_inverted_index":{"We":[0,19,62],"examine":[1],"a":[2,67,75,81],"large":[3],"class":[4],"of":[5,26,36,58,99,102],"prior":[6,70],"distributions":[7],"to":[8],"model":[9,23],"the":[10,21,27,34,42,51,85,97,100,103],"dose-response":[11],"relationship":[12],"in":[13,24,80],"cancer":[14],"phase":[15],"I":[16],"clinical":[17],"trials.":[18],"parameterize":[20],"dose-toxicity":[22],"terms":[25],"maximum":[28],"tolerated":[29],"dose":[30,37,44],"(MTD)":[31],"gamma":[32],"and":[33],"probability":[35],"limiting":[38],"toxicity":[39],"(DLT)":[40],"at":[41],"initial":[43],"rho(0).":[45],"The":[46],"MTD":[47,104],"is":[48],"estimated":[49],"using":[50],"EWOC":[52],"(escalation":[53],"with":[54,73],"overdose":[55],"control)":[56],"method":[57],"Babb":[59],"et":[60],"al.":[61],"show":[63],"through":[64],"simulations":[65],"that":[66,87],"candidate":[68],"joint":[69],"for":[71,91],"(rho0,gamma)":[72],"negative":[74],"priori":[76],"correlation":[77],"structure":[78],"results":[79],"safer":[82],"trial":[83],"than":[84],"one":[86],"assumes":[88],"independent":[89],"priors":[90],"these":[92],"two":[93],"parameters":[94],"while":[95],"keeping":[96],"efficiency":[98],"estimate":[101],"essentially":[105],"unchanged.":[106]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":10}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}